{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:11:43Z","timestamp":1759191103227,"version":"3.44.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Sanming Project of Medicine in Shenzhen","award":["SZSM202211013","SZSM202211013","SZSM202211013"],"award-info":[{"award-number":["SZSM202211013","SZSM202211013","SZSM202211013"]}]},{"name":"The Shenzhen Key Medical Discipline Construction Fund","award":["SZXK009","SZXK009","SZXK009"],"award-info":[{"award-number":["SZXK009","SZXK009","SZXK009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04450-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:04:33Z","timestamp":1759154673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kansas city cardiomyopathy questionnaire in cardiac function assessment of chronic kidney disease patients: a literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiafang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"11","key":"4450_CR1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372. https:\/\/doi.org\/10.1161\/circulationaha.120.050686.","journal-title":"Circulation"},{"key":"4450_CR2","doi-asserted-by":"publisher","unstructured":"House AA, Wanner C, Sarnak MJ, Pi\u00f1a IL, McIntyre CW, Komenda P, et al. Heart failure in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(6):1304\u201317. https:\/\/doi.org\/10.1016\/j.kint.2019.02.022.","DOI":"10.1016\/j.kint.2019.02.022"},{"issue":"5","key":"4450_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.semnephrol.2021.09.010","volume":"41","author":"L Villegas","year":"2021","unstructured":"Villegas L, Amaral S. Patient-Reported outcomes in children with chronic kidney disease. Semin Nephrol. 2021;41(5):476\u2009\u2212\u200984. https:\/\/doi.org\/10.1016\/j.semnephrol.2021.09.010.","journal-title":"Semin Nephrol"},{"issue":"1","key":"4450_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchf.2019.06.013","volume":"8","author":"S Angraal","year":"2020","unstructured":"Angraal S, Mortazavi BJ, Gupta A, Khera R, Ahmad T, Desai NR, et al. Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction. JACC Heart Fail. 2020;8(1):12\u201321. https:\/\/doi.org\/10.1016\/j.jchf.2019.06.013.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"4450_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069\u201384. https:\/\/doi.org\/10.1056\/NEJMoa2306963.","journal-title":"N Engl J Med"},{"issue":"36","key":"4450_CR6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"issue":"27","key":"4450_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","journal-title":"Eur Heart J"},{"key":"4450_CR8","doi-asserted-by":"publisher","unstructured":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223-49.https:\/\/doi.org\/10.1016\/s0140-6736(20)30752-2","DOI":"10.1016\/s0140-6736(20)30752-2"},{"issue":"4","key":"4450_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40620-019-00617-y","volume":"32","author":"S Bianchi","year":"2019","unstructured":"Bianchi S, Aucella F, De Nicola L, Genovesi S, Paoletti E, Regolisti G. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian society of nephrology. J Nephrol. 2019;32(4):499\u2013516. https:\/\/doi.org\/10.1007\/s40620-019-00617-y.","journal-title":"J Nephrol"},{"issue":"13","key":"4450_CR10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"JAMA"},{"issue":"4s","key":"4450_CR11","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4s):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"4450_CR12","unstructured":"Administration USFaD. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009 [Available from: https:\/\/www.fda.gov\/media\/128372\/download]"},{"key":"4450_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.compbiomed.2018.08.012","volume":"101","author":"OL Aiyegbusi","year":"2018","unstructured":"Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Walmsley-Allen N, et al. Development and usability testing of an electronic patient-reported outcome measure (ePROM) system for patients with advanced chronic kidney disease. Comput Biol Med. 2018;101:120\u20137. https:\/\/doi.org\/10.1016\/j.compbiomed.2018.08.012.","journal-title":"Comput Biol Med"},{"issue":"2","key":"4450_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.ajkd.2019.02.011","volume":"74","author":"OL Aiyegbusi","year":"2019","unstructured":"Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Walmsley-Allen N, et al. Patient and clinician perspectives on electronic Patient-Reported outcome measures in the management of advanced CKD: A qualitative study. Am J Kidney Dis. 2019;74(2):167\u201378. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.011.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"4450_CR15","doi-asserted-by":"publisher","first-page":"e021532","DOI":"10.1136\/bmjopen-2018-021532","volume":"8","author":"NE Anderson","year":"2018","unstructured":"Anderson NE, Calvert M, Cockwell P, Dutton M, Aiyegbusi OL, Kyte D. Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol. BMJ Open. 2018;8(10):e021532. https:\/\/doi.org\/10.1136\/bmjopen-2018-021532.","journal-title":"BMJ Open"},{"issue":"9","key":"4450_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/ndt\/gfaa364","volume":"36","author":"ME Grams","year":"2021","unstructured":"Grams ME, Surapaneni A, Appel LJ, Lash JP, Hsu J, Diamantidis CJ, et al. Clinical events and patient-reported outcome measures during CKD progression: findings from the chronic renal insufficiency cohort study. Nephrol Dial Transpl. 2021;36(9):1685\u201393. https:\/\/doi.org\/10.1093\/ndt\/gfaa364.","journal-title":"Nephrol Dial Transpl"},{"key":"4450_CR17","unstructured":"Hays RD, Kallich Jd Fau - Mapes DL, Mapes Dl Fau - Coons SJ, Coons Sj Fau - Carter WB, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. (0962\u20139343 (Print))."},{"issue":"2","key":"4450_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpainsymman.2018.04.006","volume":"56","author":"R Raj","year":"2018","unstructured":"Raj R, Ahuja K, Frandsen M, Murtagh FEM, Jose M. Validation of the IPOS-Renal symptom survey in advanced kidney disease: A Cross-sectional study. J Pain Symptom Manage. 2018;56(2):281\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.04.006.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"4450_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333. https:\/\/doi.org\/10.1097\/00005650-199603000-00003.","journal-title":"Med Care"},{"issue":"4","key":"4450_CR20","doi-asserted-by":"publisher","first-page":"e1003954","DOI":"10.1371\/journal.pmed.1003954","volume":"19","author":"BR Fletcher","year":"2022","unstructured":"Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P, et al. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954. https:\/\/doi.org\/10.1371\/journal.pmed.1003954.","journal-title":"PLoS Med"},{"issue":"5","key":"4450_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245\u201355. https:\/\/doi.org\/10.1016\/s0735-1097(00)00531-3.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4450_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11886-021-01511-5","volume":"23","author":"RA Garcia","year":"2021","unstructured":"Garcia RA, Benton MC, Spertus JA. Patient-Reported outcomes in patients with cardiomyopathy. Curr Cardiol Rep. 2021;23(7):91. https:\/\/doi.org\/10.1007\/s11886-021-01511-5.","journal-title":"Curr Cardiol Rep"},{"issue":"20","key":"4450_CR23","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","volume":"76","author":"JA Spertus","year":"2020","unstructured":"Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City cardiomyopathy questionnaire in clinical trials and clinical care: JACC State-of-the-Art review. J Am Coll Cardiol. 2020;76(20):2379\u201390. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.542.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4450_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jchf.2022.03.003","volume":"10","author":"J Butler","year":"2022","unstructured":"Butler J, Shahzeb Khan M, Lindenfeld J, Abraham WT, Savarese G, Salsali A, et al. Minimally clinically important difference in health status scores in patients with HFrEF vs HFpEF. JACC Heart Fail. 2022;10(9):651\u201361. https:\/\/doi.org\/10.1016\/j.jchf.2022.03.003.","journal-title":"JACC Heart Fail"},{"key":"4450_CR25","unstructured":"Administration USFaD. MDDT Qualification decision summary (MDDT020). Kansas City Cardiomyopathy Questionnaire (KCCQ) 2016 [Available from: https:\/\/www.fda.gov\/media\/108301\/download]"},{"issue":"1","key":"4450_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"TF Chao","year":"2022","unstructured":"Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022;122(1):20\u201347. https:\/\/doi.org\/10.1055\/s-0041-1739411.","journal-title":"Thromb Haemost"},{"issue":"1","key":"4450_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12872-023-03265-0","volume":"23","author":"P Chillo","year":"2023","unstructured":"Chillo P, Mlay J, Akanyirige PW, Majani N, Janabi M, Kaaya S, et al. Adapting and usability testing of the Kansas City cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in tanzania: the Swahili KCCQ. BMC Cardiovasc Disord. 2023;23(1):242. https:\/\/doi.org\/10.1186\/s12872-023-03265-0.","journal-title":"BMC Cardiovasc Disord"},{"key":"4450_CR28","doi-asserted-by":"publisher","unstructured":"Dos Reis MC, Nascimento JA, de Andrade GN, Costa ACS, Takada JY, Mansur AP, et al. Validation of the Portuguese version of the Kansas City cardiomyopathy Questionnaire-12. J Cardiovasc Dev Dis. 2023;10(4). https:\/\/doi.org\/10.3390\/jcdd10040162.","DOI":"10.3390\/jcdd10040162"},{"issue":"9","key":"4450_CR29","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/ejhf.2535","volume":"24","author":"I Johansson","year":"2022","unstructured":"Johansson I, Balasubramanian K, Bangdiwala S, Mielniczuk L, Hage C, Sharma SK, et al. Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme. Eur J Heart Fail. 2022;24(9):1478\u201390. https:\/\/doi.org\/10.1002\/ejhf.2535.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4450_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12955-020-01483-0","volume":"18","author":"E Watanabe-Fujinuma","year":"2020","unstructured":"Watanabe-Fujinuma E, Origasa H, Bamber L, Roessig L, Toyoda T, Haga Y, et al. Psychometric properties of the Japanese version of the Kansas City cardiomyopathy questionnaire in Japanese patients with chronic heart failure. Health Qual Life Outcomes. 2020;18(1):236. https:\/\/doi.org\/10.1186\/s12955-020-01483-0.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"4450_CR31","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ejhf.2738","volume":"24","author":"A Chandra","year":"2022","unstructured":"Chandra A, Polanczyk CA, Claggett BL, Vaduganathan M, Packer M, Lefkowitz MP, et al. Health-related quality of life outcomes in PARAGON-HF. Eur J Heart Fail. 2022;24(12):2264\u201374. https:\/\/doi.org\/10.1002\/ejhf.2738.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"4450_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.Cir.0000136991.85540.A9","volume":"110","author":"GE Soto","year":"2004","unstructured":"Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation. 2004;110(5):546\u201351. https:\/\/doi.org\/10.1161\/01.Cir.0000136991.85540.A9.","journal-title":"Circulation"},{"issue":"9","key":"4450_CR33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ejhf.2831","volume":"25","author":"TJ Siddiqi","year":"2023","unstructured":"Siddiqi TJ, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, B\u00f6hm M, et al. Health status across major subgroups of patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2023;25(9):1623\u201331. https:\/\/doi.org\/10.1002\/ejhf.2831.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"4450_CR34","doi-asserted-by":"publisher","first-page":"e007027","DOI":"10.1161\/CIRCOUTCOMES.120.007027","volume":"13","author":"FL Mondesir","year":"2020","unstructured":"Mondesir FL, Zickmund SL, Yang S, Perry G, Galyean P, Nativi-Nicolau J, et al. Patient perspectives on the completion and use of Patient-Reported outcome surveys in routine clinical care for heart failure. Circ Cardiovasc Qual Outcomes. 2020;13(9):e007027. https:\/\/doi.org\/10.1161\/circoutcomes.120.007027.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"4450_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1053\/j.ajkd.2022.09.016","volume":"81","author":"CP Walther","year":"2023","unstructured":"Walther CP, Benoit JS, Bansal N, Nambi V, Navaneethan SD. Heart Failure-Type symptom score trajectories in CKD: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2023;81(4):446\u201356. https:\/\/doi.org\/10.1053\/j.ajkd.2022.09.016.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4450_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cardfail.2010.08.009","volume":"17","author":"MG Shlipak","year":"2011","unstructured":"Shlipak MG, Lash JP, Yang W, Teal V, Keane M, Cappola T, et al. Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure. J Card Fail. 2011;17(1):17\u201323. https:\/\/doi.org\/10.1016\/j.cardfail.2010.08.009.","journal-title":"J Card Fail"},{"issue":"4","key":"4450_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/CIRCHEARTFAILURE.115.002097","volume":"8","author":"RK Mishra","year":"2015","unstructured":"Mishra RK, Yang W, Roy J, Anderson AH, Bansal N, Chen J, et al. Kansas City cardiomyopathy questionnaire score is associated with incident heart failure hospitalization in patients with chronic kidney disease without previously diagnosed heart failure: chronic renal insufficiency cohort study. Circ Heart Fail. 2015;8(4):702\u20138. https:\/\/doi.org\/10.1161\/circheartfailure.115.002097.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"4450_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.CIR.64.6.1227","volume":"64","author":"L Goldman","year":"1981","unstructured":"Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64(6):1227\u201334. https:\/\/doi.org\/10.1161\/01.cir.64.6.1227.","journal-title":"Circulation"},{"issue":"2","key":"4450_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamacardio.2022.4427","volume":"8","author":"LE Rohde","year":"2023","unstructured":"Rohde LE, Zimerman A, Vaduganathan M, Claggett BL, Packer M, Desai AS, et al. Associations between new York heart association classification, objective measures, and Long-term prognosis in mild heart failure: A secondary analysis of the PARADIGM-HF trial. JAMA Cardiol. 2023;8(2):150\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2022.4427.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"4450_CR40","doi-asserted-by":"publisher","first-page":"e2339458","DOI":"10.1001\/jamanetworkopen.2023.39458","volume":"6","author":"X Huo","year":"2023","unstructured":"Huo X, Pu B, Wang W, Peng Y, Li J, Lei L, et al. New York heart association class and Kansas City cardiomyopathy questionnaire in acute heart failure. JAMA Netw Open. 2023;6(10):e2339458. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.39458.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4450_CR41","doi-asserted-by":"publisher","first-page":"e009134","DOI":"10.1161\/CIRCOUTCOMES.122.009134","volume":"16","author":"K Teramoto","year":"2023","unstructured":"Teramoto K, Tay WT, Tromp J, Katherine Teng TH, Chandramouli C, Ouwerkerk W, et al. Patient-Reported versus Physician-Assessed health status in heart failure with reduced and preserved ejection fraction from ASIAN-HF registry. Circ Cardiovasc Qual Outcomes. 2023;16(1):e009134. https:\/\/doi.org\/10.1161\/circoutcomes.122.009134.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"4450_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","volume":"6","author":"SJ Greene","year":"2021","unstructured":"Greene SJ, Butler J, Spertus JA, Hellkamp AS, Vaduganathan M, DeVore AD, et al. Comparison of new York heart association class and Patient-Reported outcomes for heart failure with reduced ejection fraction. JAMA Cardiol. 2021;6(5):522\u201331. https:\/\/doi.org\/10.1001\/jamacardio.2021.0372.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"4450_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ejhf.2778","volume":"25","author":"G Savarese","year":"2023","unstructured":"Savarese G, Lindenfeld J, Stolfo D, Adams K, Ahmad T, Desai NR, et al. Use of patient-reported outcomes in heart failure: from clinical trials to routine practice. Eur J Heart Fail. 2023;25(2):139\u201351. https:\/\/doi.org\/10.1002\/ejhf.2778.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4450_CR44","doi-asserted-by":"publisher","first-page":"101592","DOI":"10.1016\/j.cpcardiol.2023.101592","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, Sun Y, Gong D, Fan Y. Association between Disease-specific Health-related quality of life and All-cause mortality in patients with heart failure: A Meta-analysis. Curr Probl Cardiol. 2023;48(4):101592. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101592.","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"4450_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.amjcard.2018.11.037","volume":"123","author":"D Yee","year":"2019","unstructured":"Yee D, Novak E, Platts A, Nassif ME, LaRue SJ, Vader JM. Comparison of the Kansas City cardiomyopathy questionnaire and Minnesota living with heart failure questionnaire in predicting heart failure outcomes. Am J Cardiol. 2019;123(5):807\u201312. https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.037.","journal-title":"Am J Cardiol"},{"issue":"13","key":"4450_CR46","doi-asserted-by":"publisher","first-page":"e014385","DOI":"10.1161\/jaha.119.014385","volume":"9","author":"SL Tummalapalli","year":"2020","unstructured":"Tummalapalli SL, Zelnick LR, Andersen AH, Christenson RH, deFilippi CR, Deo R, et al. Association of cardiac biomarkers with the Kansas City cardiomyopathy questionnaire in patients with chronic kidney disease without heart failure. J Am Heart Assoc. 2020;9(13):e014385. https:\/\/doi.org\/10.1161\/jaha.119.014385.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"4450_CR47","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41366-022-01208-x","volume":"46","author":"CP Walther","year":"2022","unstructured":"Walther CP, Benoit JS, Gregg LP, Bansal N, Nambi V, Feldman HI, et al. Heart failure-type symptom scores in chronic kidney disease: the importance of body mass index. Int J Obes (Lond). 2022;46(10):1910\u20137. https:\/\/doi.org\/10.1038\/s41366-022-01208-x.","journal-title":"Int J Obes (Lond)"},{"issue":"18","key":"4450_CR48","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jacc.2025.03.009","volume":"85","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM, Murakami M, Ou Y, Borlaug BA. Interplay of chronic kidney disease and the effects of Tirzepatide in patients with heart failure, preserved ejection fraction, and obesity: the SUMMIT trial. J Am Coll Cardiol. 2025;85(18):1721\u201335. https:\/\/doi.org\/10.1016\/j.jacc.2025.03.009.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4450_CR49","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ejhf.2962","volume":"25","author":"M Yang","year":"2023","unstructured":"Yang M, Kondo T, Adamson C, Butt JH, Abraham WT, Desai AS, et al. Impact of comorbidities on health status measured using the Kansas City cardiomyopathy questionnaire in patients with heart failure with reduced and preserved ejection fraction. Eur J Heart Fail. 2023;25(9):1606\u201318. https:\/\/doi.org\/10.1002\/ejhf.2962.","journal-title":"Eur J Heart Fail"},{"issue":"suppl3","key":"4450_CR50","doi-asserted-by":"publisher","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","volume":"33","author":"M Cozzolino","year":"2018","unstructured":"Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in Dialysis patients. Nephrol Dial Transpl. 2018;33(suppl3):iii28\u201334. https:\/\/doi.org\/10.1093\/ndt\/gfy174.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4450_CR51","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","volume":"28","author":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure","year":"2022","unstructured":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1\u2013167. https:\/\/doi.org\/10.1016\/j.cardfail.2022.02.010.","journal-title":"J Card Fail"},{"issue":"18","key":"4450_CR52","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/cir.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/cir.0000000000001063.","journal-title":"Circulation"},{"issue":"5","key":"4450_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/circoutcomes.115.001958","volume":"8","author":"JA Spertus","year":"2015","unstructured":"Spertus JA, Jones PG. Development and validation of a short version of the Kansas City cardiomyopathy questionnaire. Circ Cardiovasc Qual Outcomes. 2015;8(5):469\u201376. https:\/\/doi.org\/10.1161\/circoutcomes.115.001958.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4450_CR54","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cca.2020.07.040","volume":"510","author":"X Han","year":"2020","unstructured":"Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, et al. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta. 2020;510:298\u2013310. https:\/\/doi.org\/10.1016\/j.cca.2020.07.040.","journal-title":"Clin Chim Acta"},{"key":"4450_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1200\/edbk_200383","volume":"38","author":"E Basch","year":"2018","unstructured":"Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of Patient-Reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122\u201334. https:\/\/doi.org\/10.1200\/edbk_200383.","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04450-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:04:34Z","timestamp":1759154674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4450"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04450-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}